RC
ETNB

Rangeley Capital’s 89bio ETNB Stock Holding History

Rangeley Capital’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-54,000
Closed -$794K – 136
2025
Q3 		$794K Buy
+54,000
New +$550K 0.69% 38

Other funds holding ETNB

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Rangeley Capital's ETNB Position: Q4 2025 in Review

Rangeley Capital sold out of 89bio (ETNB) in Q4 2025, closing a stake of 54,000 shares — an estimated $794K sold.

Rangeley Capital first reported a position in ETNB in Q3 2025 and held it in 1 quarter. The position peaked at $794K in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Rangeley Capital reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Rangeley Capital sold 54,000 89bio shares in Q4 2025, an estimated $794K.
  • Rangeley Capital first reported a position in 89bio in Q3 2025 and held it in 1 quarter.
  • Rangeley Capital's 89bio position peaked at $794K in Q3 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Rangeley Capital's 13F filing for Q4 2025, filed 17 Feb 2026.